Efficiency and safety of subconjunctival injection of anti-VEGF agent – bevacizumab – in treating dry eye

Overview of attention for article published in Drug Design, Development and Therapy, June 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

googleplus: 1 Google+ user

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 46 Mendeley

Summary Google+ Dimensions citations

So far, Dimensions has found 15 publications that cite this research output.

15

The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.

A Systematic Review of Tear Vascular Endothelial Growth Factor and External Eye Diseases

Article in International Journal of Molecular Sciences (January 2024)

Evidence of air pollution-related ocular signs and altered inflammatory cytokine profile of the ocular surface in Beijing

Article in Scientific Reports (November 2022)

Bevacizumab Eye Drops Vs. Intra-meibomian Gland Injection of Bevacizumab for Meibomian Gland Dysfunction-Associated Posterior Blepharitis

Article in Frontiers in Medicine (June 2022)